BLT
Click for more information
0.00% 2.6¢ benitec biopharma limited

The article references our partner Circuit Therapeutics focusing...

  1. scout41
    536 Posts.
    lightbulb Created with Sketch. 1
    clock Created with Sketch.
    29/11/17
    02:43
    Post #: 29197826
    The article references our partner Circuit Therapeutics focusing it's optogenetic therapy on pain.

    It would be interesting to know if it's feasible to combine Circuit's optogenetic therapy with our ocular franchise model to get better results.
    BLT Price at posting: 20.0¢ Sentiment: Buy Disclosure: Held
    Likes Created with Sketch.  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

SKC SkyCity to lose NZ$5M in 2025 over complaint closedown
right-arrow Created with Sketch.
ASL Andean discovers up to 4,649 AgEq through maiden drilling in Chile
right-arrow Created with Sketch.
WGX Australian foreign investment regulators greenlight Westgold's buyout of Karora
right-arrow Created with Sketch.
RIO Rio registers 2% drop in iron ore production in 2nd quarter of 2024
right-arrow Created with Sketch.
ENR Encounter sniffs 4% niobium across 1.6km of strike in WA
right-arrow Created with Sketch.
MEU Marmota hopes to punch through the ceiling of a high-grade system at Goolagong – geology willing
right-arrow Created with Sketch.
watchlist Created with Sketch. Add BLT (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.